Search research articles
Contact Us
Filters
Showing results (461-470 of 627) with videos related to
Page
of 63
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)
Larry R Jackson, Peter Schrader, Laine Thomas, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 7, 2021
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
Jemi Galani, Hillary Mulder, Frank W Rockhold, et al.
Circulation
|
November 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Brendon L Neuen, Hiddo J L Heerspink, Priya Vart, et al.
The Lancet. Diabetes & Endocrinology
|
November 28, 2024
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Sunil V Badve, Anika Bilal, Matthew M Y Lee, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 4, 2016
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience
Sergio Leonardi, Renato D Lopes, Ph Gabriel Steg, et al.
American Heart Journal
|
September 21, 2015
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
Sameer Bansilal, Zachary Bloomgarden, Jonathan L Halperin, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
December 25, 2015
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar
Jean-Pierre Déry, Kenneth W Mahaffey, Pierluigi Tricoci, et al.
American Heart Journal
|
March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trials
André Zimerman, Renato D Lopes, Amanda L Stebbins, et al.
Vascular Medicine (London, England)
|
July 12, 2018
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial
Jeffrey S Berger, Beth L Abramson, Renato D Lopes, et al.
Circulation
|
November 21, 2007
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial
Pierluigi Tricoci, Yuliya Lokhnygina, Lisa G Berdan, et al.
Page
of 63
Search research articles
Search
Showing results (461-470 of 627) with videos related to
Sort By:
Page
of 63
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)
Larry R Jackson, Peter Schrader, Laine Thomas, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 7, 2021
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
Jemi Galani, Hillary Mulder, Frank W Rockhold, et al.
Circulation
|
November 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Brendon L Neuen, Hiddo J L Heerspink, Priya Vart, et al.
The Lancet. Diabetes & Endocrinology
|
November 28, 2024
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Sunil V Badve, Anika Bilal, Matthew M Y Lee, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 4, 2016
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience
Sergio Leonardi, Renato D Lopes, Ph Gabriel Steg, et al.
American Heart Journal
|
September 21, 2015
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
Sameer Bansilal, Zachary Bloomgarden, Jonathan L Halperin, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
December 25, 2015
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar
Jean-Pierre Déry, Kenneth W Mahaffey, Pierluigi Tricoci, et al.
American Heart Journal
|
March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trials
André Zimerman, Renato D Lopes, Amanda L Stebbins, et al.
Vascular Medicine (London, England)
|
July 12, 2018
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial
Jeffrey S Berger, Beth L Abramson, Renato D Lopes, et al.
Circulation
|
November 21, 2007
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial
Pierluigi Tricoci, Yuliya Lokhnygina, Lisa G Berdan, et al.
Page
of 63